Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are…
Biotechnology
US, San Diego [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Kura Oncology, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDKura Oncology, Inc. can't present revenue by segment